BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9147285)

  • 1. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
    Devrim B; Bozkir A; Canefe K
    Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres.
    Lewis L; Boni RL; Adeyeye CM
    J Microencapsul; 1998; 15(5):555-67. PubMed ID: 9743912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies.
    Adeyeye CM; Price JC
    Pharm Res; 1994 Apr; 11(4):575-9. PubMed ID: 8058619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro evaluation of sustained release ibuprofen microspheres.
    Ghaly ES; SepĂșlveda S
    P R Health Sci J; 1996 Jun; 15(2):97-100. PubMed ID: 8936613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
    Devrim B; Canefe K
    Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.
    Oladiran GS; Batchelor HK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):106-11. PubMed ID: 17321730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
    Wu C; McGinity JW
    AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics.
    Adeyeye CM; Price JC
    Pharm Res; 1991 Nov; 8(11):1377-83. PubMed ID: 1798673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
    Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
    J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
    Bodmeier R; Wang J; Bhagwatwar H
    J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive release of indomethacin using lactan-acetate microspheres.
    Na K; Lee KY
    Drug Dev Ind Pharm; 1998 Jun; 24(6):563-8. PubMed ID: 9876624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres.
    Vilivalam VD; Adeyeye CM
    J Microencapsul; 1994; 11(4):455-70. PubMed ID: 7931945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
    Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
    J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.